Vera Therapeutics CEO Marshall Executes $1.96 Million Share Sale Under Pre-Approved Plan
Fordyce Marshall, President and CEO of Vera Therapeutics, Inc. (NASDAQ:VERA), executed a series of stock sales totaling approximately $1.96 million on July 7, 2026. The transactions involved 46,250 shares of Class A Common Stock, with prices ranging from $40.39 to $43.97 per share. These sales were carried out under a pre-arranged Rule 10b5-1 tradi…